You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 8, August 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •eTables
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Schizophrenia
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Support for NRG1 as a Susceptibility Factor for Schizophrenia in a Northern Swedish Isolated Population

Maaike Alaerts, PhD; Shana Ceulemans, MSc; Diego Forero, MD; Lotte N. Moens, PhD; Sonia De Zutter, BE; Lien Heyrman, MSc; An-Sofie Lenaerts, BA; Karl-Fredrik Norrback, MD; Peter De Rijk, PhD; Lars-Göran Nilsson, MD; Dirk Goossens, PhD; Rolf Adolfsson, MD; Jurgen Del-Favero, PhD

Arch Gen Psychiatry. 2009;66(8):828-837.

Context  Neuregulin 1 (NRG1), a growth factor involved in neurodevelopment, myelination, neurotransmitter receptor expression, and synaptic plasticity, first joined the list of candidate genes for schizophrenia when a 7-marker haplotype at the 5' end of the gene (HapICE) was shown to be associated with the disorder in the Icelandic population. Since then, more genetic and functional evidence has emerged, which supports a role for NRG1 in the development of schizophrenia.

Objective  To determine the contribution of NRG1 to susceptibility for schizophrenia in a northern Swedish isolated population.

Design  Detailed linkage disequilibrium (LD)–based patient-control association study. This is the first study to type and analyze the 7 HapICE markers and a set of 32 HapMap tagging single-nucleotide polymorphisms (SNPs) that represents variants with a minor allele frequency of at least 1% and fully characterizes the LD structure of the 5' part of NRG1.

Setting  Outpatient and inpatient hospitals.

Participants  A total of 486 unrelated patients with schizophrenia and 514 unrelated control individuals recruited from a northern Swedish isolated population.

Main Outcome Measures  Association between markers and disease.

Results  Analysis of the HapICE markers showed the association of a 7-marker and 2-microsatellite haplotype, different from the haplotypes associated in the Icelandic population and overrepresented in northern Swedish control individuals. Subsequently, a more detailed analysis that included all 37 genotyped SNPs was performed by investigating haplotypic association, dependent and independent of LD block structure. We found significant association with 5 SNPs located in the second intron of NRG1 (.007 ≤ P ≤ .04). Also, 2-, 3-, and 4-SNP windows that comprise these SNPs were associated (P < 3 x 10–4). One protective haplotype (0% vs 1.8%; P <5 x 10–5) and 1 disease risk–causing haplotype (40.4% vs 34.9%, P = .02) were defined.

Conclusion  The NRG1 gene contributes to the susceptibility for schizophrenia in the northern Swedish population.


Author Affiliations: Applied Molecular Genomics Group, Department of Molecular Genetics, Flanders Institute for Biotechnology and University of Antwerp, Belgium (Drs Alaerts, Forero, Moens, Norrback, De Rijk, Nilsson, Goosens, Adolfsson, and Del-Favero, and Mss Ceulemans, De Zutter, Heyrman, Lenaerts); Department of Clinical Sciences, Psychiatry, Umeå University and Department of Psychiatry, Hospital of Sunderby, Luleå (Drs Norrback and Adolfsson); and Department of Psychology, Stockholm University, Sweden (Dr Nilsson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.